Details for: TARO-ZOLEDRONIC ACID
Company: TARO PHARMACEUTICALS INC
| DIN | DIN name | Active Ingredient(s) | Strength | Dosage Form | Route of Administration |
|---|---|---|---|---|---|
| 02415100 | TARO-ZOLEDRONIC ACID | ZOLEDRONIC ACID (ZOLEDRONIC ACID MONOHYDRATE) | 5 MG / 100 ML | SOLUTION | INTRAVENOUS |
Consumer Information
This information was provided by the drug’s manufacturer when this drug product was approved for sale in Canada. It is designed for consumers and care givers. It is a summary of information about the drug and will not tell you everything about the drug. Contact your doctor or pharmacist if you have any questions about the drug.
What the medication is used for
Taro-Zoledronic Acid is used:
- In the treatment of osteoporosis in postmenopausal women to reduce the risk of hip, vertebral, nonvertebral fractures (breaking bone) when given once a year.
- In the treatment to increase bone mineral density in men with osteoporosis when given once a year.
- In the treatment and prevention of osteoporosis, in men and women caused by glucocorticoids medicines such as prednisone, to increase bone mineral density, when given once a year.
- In the prevention of osteoporosis in postmenopausal women with low bone mass, given as a single treatment.
- In the treatment of Paget’s disease, given as a single treatment.
What it does
Taro-Zoledronic Acid contains zoledronic acid which is a
member of a class of substances called Bisphosphonates.
Taro-Zoledronic Acid binds specifically to bone and it
does not stay in your blood. Taro-Zoledronic Acid slows
down bone resorption (caused by osteoclasts) which
allows the bone-forming cells (osteoblasts) time to rebuild
normal bone.
What is osteoporosis?
Osteoporosis is a disease that involves the thinning
and weakening of the bones, which is common in
women after menopause and may also occur in men.
What is Paget’s disease of bone?
In Paget’s disease, bone breaks down too much and
the new bone made is not normal. If Paget’s disease is
not treated, bones like the skull, spine, and legs
become deformed and weaker than normal. This can
cause problems like bone pain and arthritis. The bones
can also break easily. Paget’s disease of bone
sometimes runs in families. Paget’s disease may be
discovered by X-ray examination or blood tests.
When it should not be used
You should not be treated with Taro-Zoledronic Acid if you:
- Have low calcium levels in your blood. (Hypocalcemia) or vitamin D deficiency.
- If you have severe kidney problems.
- Are pregnant or plan to become pregnant.
- Are breast-feeding.
- Are allergic (hypersensitive) to zoledronic acid or any of the other ingredients of Taro-Zoledronic Acid or any other bisphosphonate.
What the medicinal ingredient is
Zoledronic acid.
What the non-medicinal ingredients are
Mannitol, sodium citrate, water for injection
What dosage form it comes in
Taro-Zoledronic Acid is a clear, colorless solution for intravenous infusion and it comes in a 100 mL clear glass vial with a golden red flip off aluminum seal. Each 100 mL solution contains 5 mg of zoledronic acid.
Warnings and precautions
Be sure that you have discussed Taro-Zoledronic Acid
treatment with your doctor.
If you are being treated with another intravenous form
of zoledronic acid, you should not be treated with
Taro-Zoledronic Acid.
If you are being treated with Taro-Zoledronic Acid,
you should not be treated with other bisphosphonates
(such as alendronate, risedronate, clodronate,
etidronate, ibandronate and pamidronate) at the same
time.
Your doctor should inspect your mouth and may
ask that you have a dental examination prior to
treatment with Taro-Zoledronic Acid. Denta
work should be done before you receive treatment
with Taro-Zoledronic Acid and dental procedures
should be avoided during treatment. It is important
that you practice good dental hygiene, routine dental
care and have regular dental check-ups while being
treated with Taro-Zoledronic Acid. Immediately
report any oral symptoms such as loosening of a tooth,
pain, swelling, or non- healing open wounds or sores
or discharge (pus or oozing) during your treatment
with Taro-Zoledronic Acid.
BEFORE you use Taro-Zoledronic Acid talk to your
doctor or pharmacist if you:
- Are of advanced age.
- Do not have enough water in your body (dehydration) before or after you receive Taro-Zoledronic Acid.
- Are unable to take daily calcium and/or vitamin D supplements.
- Are pregnant or plan to become pregnant.
- Are breast-feeding.
- Have kidney problems. Worsening of kidney function, including kidney failure may happen when you take Taro-Zoledronic Acid.
- Had some or all of your parathyroid glands or thyroid gland surgically removed.
- Had sections of your intestine removed.
- Need any dental procedures such as a root canal or tooth extraction (this does not include regular dental cleaning). Your doctor may possibly request a dental examination with any necessary preventive dentistry carried out prior to treatment with Taro-Zoledronic Acid.You should continue regular dental cleanings and practice good oral hygiene.
- Have rapid and irregular heart beat.
- Have a sudden headache, numbness in your face or limbs, particularly down one side of your body; experience confusion and have trouble talking or understanding what is being said to you; have vision problems, and trouble walking or keeping your balance.
- Have asthma from taking ASA (acetylsalicylic acid such as Aspirin® ).
- Have any pain in your hip, groin, or thigh. TaroZoledronic Acid can cause unusual fractures in the thigh bone.
- Had or have pain, swelling or numbness of the jaw or loosening of a tooth or any other oral symptoms.
- Have sores in your mouth. This can lead to osteonecrosis of the jaw. Your doctor may check if you:
- smoke
- have or have had tooth and/or gum disease
- have dentures that do not fit well
- have other medical conditions at the same time, such as: low red blood cell count (anemia) or if your blood cannot form clots in the normal way.
- Your doctor may tell you to stop taking TAROZOLEDRONIC ACID until all sores in your mouth are healed.
- Had or have joint stiffness, aches and pains and difficulty in movement (including of the hip, thigh, knee or upper arm) or pain in the ear, tell your doctor, as this may be a sign of bone damage due to loss of blood supply (osteonecrosis).
Taro-Zoledronic Acid is to be given by intravenous infusion in no less than 15 minutes.
Interactions with this medication
Tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including any you have bought without a prescription. It is especially important for your doctor to know if you are taking:
- any medicines known to be harmful to your kidneys (such as nonsteroidal antiinflammatory drugs (NSAIDs)).
- water pill (diuretics).
- aminoglycoside antibiotics (a type of medicine used to treat severe infections).
- calcitonin (a type of medicine used to treat high calcium levels in the blood).
- angiogenesis inhibitors (type of medicines used to treat cancer).
Proper use of this medication
How is Taro-Zoledronic Acid given?
Taro-Zoledronic Acid is given as an infusion into a
vein for 15 minutes by your doctor or nurse.
Your doctor will ask you to drink at least two glasses
of water (500 mL or 2 cups) before and after the
treatment.
Usual Dose
For treatment of Osteoporosis: single dose of 5 mg once
yearly.
For prevention of Osteoporosis: single treatment of 5 mg.
For Paget’s disease: single treatment of 5 mg. TaroZoledronic Acid may work for longer than one year, and
your doctor will let you know if you need to be treated
again.
The infusion nurse or doctor may ask you to stay for a
short period of time after the infusion.
It is very important to take calcium and vitamin D
supplements as directed by your doctor to reduce the
possibility of having low blood calcium levels, to prevent
loss of bone and to help rebuild bone.
Overdose
Side effects and what to do about them
Like all medicines, Taro-Zoledronic Acid may have some
unwanted side effects in addition to its beneficial effects.
The most common side effects
Post-dose symptoms include:
- Fever
- Fatigue
- Chills
- Malaise (unwell feeling)
- Bone, joint and/or muscle pain or stiffness.
- Headache
- Nausea
- Vomiting
- Abdominal pain
- Diarrhea
- Back Pain
- Pain in extremity
- Influenza-like illness
- Weakness
- Pain
- Shortness of breath
- Dizziness
- Excessive sweating
- Tiredness
- Disturbed digestion
- Decreased appetite
- Non-cardiac chest pain
- Low blood calcium (hypocalcemia) the symptoms include numbness or tingling sensations (especially in the area around the mouth) or muscle spasms. Contact your doctor immediately if you notice any of these symptoms after your Taro-Zoledronic Acid treatment..
- Allergic reactions such as itchy rash and swelling mainly of the face and throat..
- Increased or irregular heartbeat.
- Rheumatoid arthritis/arthritis (inflammation of the joints).
- Urinary tract infection.
- Constipation.
- High blood cholesterol levels.
- Pain in jaw.
- Pain in neck.
- Joint sprain.
- Post-traumatic pain.
- Cough.
- Congestion of the nose.
- Pharyngolaryngeal pain (pain at the back of the mouth and in the voice box).
- Seasonal allergy.
- Vaginal dryness.
- Sciatica (pain in the leg caused by injury to or compression of sciatic nerve).
- Hypothesia (reduced sense of touch).
- Rare cases of dehydration.
- Persistent post-dose symptoms.
- Jaw bone problems: rarely, patients have jaw problems associated with delayed healing and infection, often following tooth extraction..
- Very rare cases of low blood pressure.
- Very rare cases of unusual fractures in a specific part of the thigh bone. If you develop new or unusual pain the thigh or groin, contact your doctor.
| Symptom / effect | Talk with your doctor, nurse, or pharmacist only if severe | Talk with your doctor, nurse, or pharmacist in all cases | |
|---|---|---|---|
| Common | |||
| Post-dose symptoms: fever, chills, fatigue, pain, malaise | ✔ | ||
| Bone, joint, and/or muscle pain or stiffness | ✔ | ||
| Headache | ✔ | ||
| Nausea, vomiting, diarrhea, abdominal pain | ✔ | ||
| Shortness of breath | ✔ | ||
| Dizziness | ✔ | ||
| Excessive sweating | ✔ | ||
| Rash | ✔ | ||
| Uncommon | |||
| Tiredness, weakness, lethargy | ✔ | ||
| Hypocalcemia (low blood calcium): numbness, tingling sensation (especially in the area around the mouth), muscle spasms | ✔ | ||
| Rapid and irregular heartbeat, palpitations | ✔ | ||
| A sudden headache, numbness in your face or limbs, particularly down one side of your body; experience confusion and have trouble talking or understanding what is being said to you; have vision problems, and trouble walking or keeping your balance | ✔ | ||
| Kidney failure: weakness, tiredness, loss of appetite, puffy eyes, hands and feet, changes in urine color or absence of urine production, changes in kidney function laboratory tests | ✔ | ||
| Eye disorder: Eye pain, light sensitivity, eye redness, decrease vision, eye inflammation | ✔ | ||
| Skin reactions: redness, swelling and/or pain at the infusion site | ✔ | ||
| Rare | |||
| Osteonecrosis of the jaw: numbness or feeling of heaviness in the jaw, poor healing of the gums especially after dental work, loose teeth, exposed bone in mouth, pain in the mouth, teeth or jaw, sores or non-healing sores in the mouth or discharge, dry mouth, swelling or gum infections, bad breath | ✔ | ||
| Very Rare | |||
| Difficulty breathing with wheezing or coughing in asthma patients who are allergic to ASA | ✔ | ||
| Avascular necrosis (osteonecrosis) of the hip or knee or upper arm: poor blood supply to an area of bone leading to bone death: bone pain, joint pain, muscle spasms, joint stiffness | ✔ | ||
| Persistent ear pain | ✔ | ||
| Failure of broken bone to heal (non-union) or broken bone taking longer than usual to heal (delayed union): persistent pain at the fracture site, no or slow progress in bone healing on imaging tests | ✔ | ||
| Severe allergic reactions: rash, hives, swelling of the face, lips, tongue or throat, difficulty swallowing or breathing , loss of consciousness due to shock (dangerously low blood pressure) | ✔ | ||
| Thigh or groin pain | ✔ | ||
| Unknown | |||
| Hypophosphatemia (low level of phosphate in blood): muscle weakness with trouble to swallow; you may be confused and irritable | ✔ | ||
If you have questions about these side effects, talk to your
doctor.
This is not a complete list of side effects. For any
unexpected effects while taking Taro-Zoledronic Acid,
contact your doctor or pharmacist.
How to store
Store Taro-Zoledronic Acid at room temperature (between 15°C – 30°C).
Keep the original packaging unchanged and sealed
until the doctor or nurse administers Taro-Zoledronic
Acid.
Remember to keep Taro-Zoledronic Acid and all
medications safely away from children.
Reporting side effects
You can report any suspected adverse reactions associated with the use of health products to the Canada Vigilance Program by one of the following three ways:
- Report online at www.healthcanada.gc.ca/medeffect
- Call toll-free at 1-866-234-2345
- Complete a Canada Vigilance Reporting Form and:
- Fax toll-free to 1-866-678-6789, or
- Mail to:
Canada Vigilance Program
Health Canada
Postal Locator 0701E
Ottawa ON K1A 0K9
Postage paid labels, Canada Vigilance Reporting Form and the adverse reaction reporting guidelines are available on the MedEffectTM Canada Web site at www.healthcanada.gc.ca/medeffect.
NOTE: Should you require information related to the management of side effects, contact your health professional. The Canada Vigilance Program does not provide medical advice.
More information
This document plus the full product monograph,
prepared for health professionals can be found at:
http://www.taro.ca
or by contacting the sponsor,
Taro Pharmaceuticals Inc.
130 East Drive, Brampton
Ontario L6T 1C1
Toll-free telephone: 1-800-268-1975
This Leaflet was prepared by Taro Pharmaceuticals
Inc.
Last revised: April 23, 2019